Showing 901 - 920 results of 101,598 for search '(( 5 ((greater decrease) OR (nn decrease)) ) OR ( 5 ((c decrease) OR (a decrease)) ))', query time: 1.49s Refine Results
  1. 901
  2. 902
  3. 903
  4. 904

    Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

    Published 2012
    “…<p>DBA/1 (A) mice and C57BL/6 mice (B) were treated daily with laquinimod (25 mg/kg, n = 6/group) or vehicle (water, n = 6/group) starting from the day of immunization with rMOG 1-125 (DBA/1) or MOG p35-55 (C57BL/6). …”
  5. 905

    Virus replication is decreased by treatment of HDAC inhibitors. by Angelika Danielsson (229695)

    Published 2011
    “…<p>LNCaP and PC-346C were transduced with Ad[i/PPT-E1A, E3] and Ad5 wt and BON cells were transduced with Ad[CgA-E1A] and Ad5 wt. …”
  6. 906
  7. 907

    L-sel decreases the number of circulating lymphocytes. by Izabela Rozenberg (214521)

    Published 2011
    “…<p><i>ApoE</i><sup>−<i>/</i>− </sup><i>L-sel</i><sup>−<i>/</i>−</sup> animals exhibit increased number of <b>A</b>) total blood lymphocytes (n = 5–8; <sup>*</sup>p<0.05), <b>B</b>) T-cytotoxic cells (CD8<sup>+</sup>; n = 6–7; <sup>**</sup>p<0.01, <sup>#</sup>p<0.05), <b>C</b>) B lymphocytes (CD19<sup>+</sup>; n = 5–7; <sup>*</sup>p<0.05, <sup>#</sup>p<0.05), <b>D</b>) total T-helper cells (CD4<sup>+</sup>; n = 6–7; <sup>#</sup>p<0.0), <b>E</b>) naive T-helper cells (CD4<sup>+</sup>CD44<sup>−</sup>; n = 5–7; <sup>*</sup>p<0.05; <sup>##</sup>p<0.0001) after 6 and 12 weeks of HCD, respectively. …”
  8. 908
  9. 909
  10. 910
  11. 911
  12. 912
  13. 913
  14. 914
  15. 915

    The decrease of C/EBPα protein during apoptosis involves induction of protein degradation and inhibition of transcription. by Meng Zhao (54299)

    Published 2009
    “…Then, C/EBPα protein was detected with β-actin as a loading control. …”
  16. 916
  17. 917
  18. 918
  19. 919
  20. 920

    BA decreases DUB activity in PC cells. by Teresita Reiner (281437)

    Published 2013
    “…(<b>B</b>) DUB assay showed that BA treatment of LNCaP cells significantly decreased DUB activity at 24 and 48 h relative to control treated cells ( = 1) (*, <i>P</i><5×10<sup>−5</sup>). …”